Breast reconstruction not can enhance the body image of women but also can have a positive effect on sexual and social factors in a woman's life [1]. Among the cases of breast reconstruction surgery, the number of cases of immediate breast reconstruction surgery has recently increased significantly because the procedure can reduce the patient's shock when seeing herself after mastectomy and can reduce medical costs because the surgery is performed only once. Among the cases of mastectomy, performing immediate breast reconstruction after skin-sparing mastectomy has been shown to be cosmetically superior to radical mastectomy or modified radical mastectomy, and various long-term studies have shown that locoregional recurrence or complications of cancer have not increased as significantly as with radical mastectomy. Regarding locoregional mastectomy and skin-sparing mastectomy, skin-sparing mastectomy is attempted when breast-conserving surgery cannot be performed because malignant calcified deposits have spread to a wide area of the breast, or several cancers are located at the center of the breast, around the nipples. After performing any of these procedures, adjuvant therapy will be essential for preventing locoregional recurrence or metastasis. While adjuvant therapy after mastectomy has the advantages of preventing locoregional recurrence of breast cancer and improving the average survival rate [1-5], it can cause various complications with respect to the stability of the flaps [2]. Whether performing adjuvant therapy after immediate breast reconstruction, in contrast to delayed breast reconstruction, has an impact on flap stability remains under dispute. In studies up to the present, delayed breast reconstruction has had a lower incidence of complications from postoperative chemotherapy or radiotherapy than immediate breast reconstruction; hence, delayed breast reconstruction has been recommended over immediate breast reconstruction [2,3].

According to the preoperative stage, 37 patients were in stage 0, 91 patients were in stage I, 55 patients were in stage IIA, 10 patients were in stage IIB, 4 patients were in stage IIIA, 3 patients were in stage IIIB, and 4 patients were in stage IIIC. The amount of excision according to the each stage was 197.5 g in stage 0, 118.4 g in stage I, 177.6 g in stage IIA, 260 g in stage IIB, 134.3 g in stage IIIA, 145 g in stage IIIB, and 120.6 g in stage IIIC (Table 2).

Among the 204 patients, 101 patients underwent both chemotherapy and radiotherapy, postoperatively, 22 patients underwent postoperative chemotherapy only, and 60 patients underwent postoperative radiotherapy only; 21 patients did not undergo adjuvant therapy after immediate breast reconstruction (Table 3).

A total of 123 patients underwent postoperative chemotherapy and began therapy on average 24.4 days after breast reconstruction, and there was no difference between this average number of days before the start of the therapy and that of the group that did not undergo the chemotherapy without breast reconstruction after mastectomy. The patients were treated with a combination of adriamycin (or epirubicin) and cyclophosphamide, administered in 4 cycles. There were differences, however, in chemotherapy according to the results of the sentinel lymph node biopsies. Taclipaxel was administered in 4 cycles in the group that had positive sentinel lymph node biopsy results, but there was no increase in the incidence of special complications in the patient group that received additional therapy.

Radiotherapy was performed on a total of 161 patients. The level of radiation on the entire breast was 5,040 to 6,040 cGY. This therapy was administered 22 times on 150 patients and 28 times on 11 patients. Radiotherapy was administered an average of 32.3 days, which did not significantly differ from that of the group that underwent radiotherapy without breast reconstruction. Among the patients who underwent breast reconstruction, an additional 1,000 cGY of radiotherapy was performed on the primary lesion according to the size of the tumor, the conditions that surrounded the lumpectomy, and the surgical method. It was performed to prevent the locoregional recurrence of the primary lesion due to the greater risk of recurrence with partial mastectomy.

Among the total of 183 patients that underwent postoperative adjuvant therapy, 162 (88.6%) patients had no complication after adjuvant therapy (Figs. 1-​-3),3), and 21 (11.4%) patients had complications. Of these, 4 patients (2.4%) had redness (Fig. 4); 4 (2.4%), swelling; 5 (2.3%), flap hardening; 4 (1.8%), hyperpigmentation (Fig. 5); 4 (1.8%), fat necrosis; 1 (0.6%), bullae; 1 (0.4%), flap contraction (Fig. 6); and there was no flap necrosis or loss.

On the other hand, delayed breast reconstruction provides time for physical recovery after mastectomy, and makes it easier to verify the complete recovery by observing the progress of the breast cancer treatment. It has the disadvantages, however, of requiring more frequent surgeries and requiring breast reconstruction using autologous tissue due to the extreme lack of flexibility because of the cicatricial contracture.

Additionally, according to Wellisch et al. [7], 60% of patients who have undergone delayed breast reconstruction have shown a mentally hypersensitive reaction that included obsessive-compulsive reaction, hypersensitivity in personal relations, depression, hostility, paranoia, and rage. Even in this study, 12 (75%) of the 16 patients who underwent delayed breast reconstruction showed mentally hypersensitive reactions, though there were differences in the severity of their reactions after surgery. However, only 21 (10%) of the 204 patients who underwent immediate breast reconstruction complained of a sense of loss or depression after the surgery. Therefore, immediate breast reconstruction can also be deemed superior with regard to these mental impacts. Hence, despite the advantages of delayed breast reconstruction, the number of cases of immediate breast reconstruction is increasing due to its cosmetic, mental, and economic advantages.

Numerous studies have shown that breast reconstruction using autologous tissue has resulted in a lower incidence of complications after postoperative adjunctive therapy and superior cosmetic results compared to breast reconstruction using a prosthesis [2-4]; moreover, in the authors' hospital, a method that employs autologous tissue was used when performing breast reconstruction. Among the autoplasty methods, reconstructive surgery using LD pedicled flap or TRAM flap was performed. The LD pedicled flap was used extensively for local excisions and when the breast on the opposite side was not too large. The reconstruction with TRAM flap was used after total mastectomy and when the breast on the tendon side was relatively big. Up to the present, approximately 200 random clinical trials have been performed for postoperative adjuvant therapy, among which many of these studies carried out follow-up observations of patients for over 20 years and have come up with a definite conclusion on the treatment results. Unlike in the past, not only has adjuvant therapy after mastectomy been mostly performed in the recent stage, but also in the initial stages; and it has been developed because it prevents locoregional recurrence of breast cancer and enhances the average survival rate [8,9]. Despite these advantages, however, it may cause various complications such as delayed healing, skin necrosis, discoloration, fat necrosis, flap necrosis, flap contraction, flap contracture, flap deformation, flap hardening, infection, and inflammation.

According to a recently announced thesis, a group that had received adjuvant therapy after immediate breast reconstruction using autologous tissue had a high incidence of complications, but its patient satisfaction did not significantly differ from that of the group that had not received adjuvant therapy. Moreover, the incidence of complications in the group that received adjuvant therapy after immediate breast reconstruction using autologous tissue was slightly higher than that in the group that had undergone delayed breast reconstruction, but the first group showed superior results in patient satisfaction [4]. Similar results were achieved in this study. There was no incidence of complications in the group that did not undergo adjuvant therapy, and it scored 3.25 points in patient satisfaction. In the group that underwent adjuvant therapy after immediate breast reconstruction, complications occurred in 21 (11.4%) of the total of 183 patients, and the score for patient satisfaction was 3.11 points. In the group of patients who underwent delayed breast reconstruction, the patient satisfaction score was 3.15 points.

The analysis of the results of this study showed that the group that had undergone adjuvant therapy after immediate breast reconstruction had a high incidence of complications, which did not significantly differ, however, from that of the patient group that did not undergo adjuvant therapy. Moreover, the former group showed no incidence of major complications related to flaps, and among these, even most of the complications that occurred were observed to have disappeared within 6 months after adjuvant therapy. From the perspective of patient satisfaction, there was no significant difference (P>0.05) compared to the group that did not receive adjuvant therapy and the group that underwent delayed breast reconstruction.

Such findings might have resulted from the technological advances in radiotherapy and the development of surgical methods.

The development of the medical linear accelerator in the 1950s, the performance of 3D therapy design, and irradiation using computers since the late 1990s have reduced the side effects of radiation and have made it possible to perform more effective radiotherapy by irradiating more precisely, that is, only irradiating the cancerous tissue. Moreover, 5,040-6,040 cGy of irradiation is divided and irradiated in 28 to 33 smaller doses. This method, which is effective against tumors and minimally damages the flaps, can also reduce radiation-induced side effects of the flaps due.

According to numerous studies, various complications may arise depending on the length of time after the irradiation. In the initial stages of the disease, these possible complications include breast edema, fat necrosis, calcification, radiation-induced tuberculosis, and pleural effusion; and in the intermediate stages, breast fibrosis, contraction of the mammary glands, difficulty in breastfeeding, fracture of the irradiated area, pulmonary fibrosis, and pericardial disease. In the latter stages, cardiac disorder or a radiation-induced malignant tumor may occur [10-12]. Viewing the effects of radiotherapy from the perspective that it reduces the locoregional recurrence of a postoperative primary tumor and further improves the survival rate, it will become a meaningless medical procedure if it does not help enhance the final survival rate due to the occurrence of various complications after radiotherapy. Therefore, the exposure dose of 5,040-6,040 cGy investigated by the authors is the dose that can minimize complications while reducing the locoregional recurrence of the postoperative primary site, and it is the exposure dose that can effectively improve the final survival rate. Because contact radiography using photon and electron beams, and 3D therapy technology that performs more precise and accurate irradiation while searching for the target, are now being developed, more effective radiotherapy will be performed in the future. Even surgical procedures will become more effective due to technological advances such as those that cause minimal damage to the flaps and the flap pedicle. In addition to the gradual development of radiotherapy and surgical methods, efforts should be made to ensure further flap stabilization and more satisfactory patient results even after the performance of adjuvant therapy following immediate breast reconstruction.